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Abstract: Evaluation of the genetic contribution to the development of
recurrent acuteotitismedia (rAOM) remains challenging. This study aimed
to evaluate the potential association between single nucleotide polymorph-
isms (SNPs) in selected genes and rAOM and to analyze whether genetic
variations might predispose to the development of complicated recurrent
cases, such as those with tympanic membrane perforation (TMP).
A total of 33 candidate genes and 47 SNPs were genotyped in 200
children with rAOM (116 with a history of TMP) and in 200 healthy
controls.
INFg rs 12369470CT was significantly less common in the children
with rAOM than in healthy controls (odds ratio [OR] 0.5, 95% confidence
interval [CI] 0.25–1, P¼ 0.04). Although not significant, interleukin (IL)-
1b rs 1143627G and toll-like receptor (TLR)-4 rs2737191AG were less
frequently detected in the children with rAOM than in controls. The
opposite was true for IL-8 rs2227306CT, which was found more fre-
quently in the children with rAOM than in healthy controls. The IL-10
rs1800896TC SNP and the IL-1a rs6746923A and AG SNPs were
significantlymore and less common, respectively, among children without
a history of TMP than among those who suffered from this complication
(OR 2.17, 95% CI 1.09–4.41, P¼ 0.02, and OR 0.42, 95% CI 0.21–0.84,
P¼ 0.01).
This study is the first report suggesting an association between variants
in genes encoding for factors of innate or adaptive immunity and the
occurrence of rAOM with or without TMP, which confirms the role ofara Rosazza, MD, ero, PhD,
Nicola Principi, MD
Abbreviations: AOM = acute otitis media, BFIFA4P = BPI fold
containing family A member 3 (BPIFA3) and 4P, CAPN14 =
calpain 14, CI = confidence interval, DNAH5 = dynein axonemal
heavy chain 5, FAS = Fas cell surface death receptor, FBXO11 = F-
box protein 11, IFN = interferon, IL = interleukin, LTA =
lymphotoxin a, MBL2 = mannose-binding lectin 2, MUC2 =
mucin 2, MUC5AC/AB = mucin 5AC/AB, NOS2 = nitric oxide
synthase 2, OME = otitis media with effusion, OR = odds ratio,
PARP1 = poly(ADP-Ribose) polymerase-1, rAOM = recurrent
acute otitis media, SCN1b = sodium channel voltage-gated type I
beta subunit, serpine1 = serine protease inhibitors, SFTPD =
surfactant protein D, SLC11A1 = proton-coupled divalent metal
ion transporter member 1, SLFN5 = schlafen family member 5),
SMAD2 = receptor-regulated SMAD2, SMAD4 = receptor-
regulated SMAD4, SNPs = single nucleotide polymorphisms,
TGF = transforming growth factor, TLRs = toll-like receptors,
TMP = tympanic membrane perforation, TNF = tumor necrosis
factor interferon-g (IFN-g), TP73 = tumor protein 73, TGFB1 =
transforming growth factor b1.
INTRODUCTION
A cute otitis media (AOM) is a very common disease. Morethan 90% of children suffer fromAOM in the first 5 years of
life.1 Moreover, in 20% to 30% of these children, AOM tends to
recur, ultimately causing significant medical, social, and
economic problems.1,2 Several factors, including young age,
day care attendance, and passive smoke exposure, have been
associated with an increased risk of recurrent AOM (rAOM).
However, it has been shown that host genetic factors signifi-
cantly influence the risk of developing AOM.3 It has been
calculated that AOM susceptibility is 40% to 60% heritable,4
although the exact mechanisms for this heritability have not
been precisely described. Because AOM is an infectious disease
and because the innate and adaptive immune systems play a
fundamental role in the defense from infectious agents, most
studies that were specifically designed to evaluate the potential
role of genetics in conditioning rAOM have evaluated the
association between variants of genes that encode factors of
innate and adaptive immunity and susceptibility to AOM. With
regard to innate immunity, genes encoding toll-like receptors
(TLRs), CD14, mannose-binding lectins, and surfactants have
been the most extensively studied.5 Regarding adaptive immu-
nity, studies have primarily focused on genes encoding various
cytokines, such as interleukin-1, (IL-1), IL-6, IL-10, transform-
ing growth factor-b (TGF-b), tumor necrosis factor a (TNF-a),-g).5 Additionally, some genome-wide
rAOM susceptibility have been per-
own genetic polymorphisms that seem
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to lead to a predisposition to AOM have been identified, and
genome-wide linkage scans have suggested multiple candidate
regions of the genome that could be associated with rAOM.5,9
However, evaluating the genetic contribution to the devel-
opment of a disease such as AOM, which is multifactorial in
etiology, remains challenging. Most of the data collected to date
could be debated. Their relevance varies significantly from
study to study and according to the ethnicity and characteristics
of the children. Finally, all of these studies have evaluated
rAOM as a whole, without considering that in this complex
condition, complicated and uncomplicated cases are included
and genetics might play a role in conditioning the different
clinical pictures. This study was designed to evaluate the
potential association between single nucleotide polymorphisms
(SNPs) in selected genes and rAOM and to analyze whether
genetic variations might predispose to the development of
complicated recurrent cases, such as those with tympanic
membrane perforation (TMP).
METHODS
Study Population and Recruitment
The study was carried out between November 1, 2014, and
January 31, 2015, and it involved children in the age group 1 to 5
yearswho had a history of rAOM(defined as at least 3 episodes in
the preceding 6 months or at least 4 episodes in the preceding 12
months, with the most recent episode in the previous 2–8 weeks)
and were regularly followed by the Outpatient Clinic of the
Pediatric High Intensive Care Unit at Fondazione IRCCS Ca’
Granda Ospedale Maggiore Policlinico, University of Milan,
Milan, Italy. Theminimum number of episodes of AOM required
to include patients in the otitis-prone group must have been
diagnosed by pneumatic otoscopy at the Outpatient Clinic of
the Pediatric High Intensive Care Unit and documented by
medical records, with at least 2 of these episodes also supported
by tympanometric findings. The exclusion criteria were all of the
factors that can, per se, favor the development of AOM, including
severe atopy, acquired or congenital immunodeficiency, cleft
palate, a chronically ruptured eardrum, craniofacial abnormalities
or obstructive adenoids, sleep apnea syndrome, or the placement
of tympanostomy tubes.
Upon enrollment, the demographic characteristics and
medical history of the children were systematically recorded
using standardized written questionnaires, paying particular
attention to the characteristics of AOM and the occurrence in
each episode of TMP. Finally, a 3mL whole blood sample was
obtained for genetic studies.
As the control group, a similar number of age- and gender-
matched children without rAOM was enrolled, and a blood
sample was drawn for genetic analyses.
The protocol was approved by the Ethics Committee of the
Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico,
Milan, Italy, and written informed consent was obtained from the
parents or legal guardian of each subject before enrollment.
Genetic Studies
Thirty-three candidate genes and 47 single nucleotide
polymorphisms (SNPs) were selected for analysis, including
genes that are involved in immune regulation, the pathogenesis
of inflammation, and the regulation of cell metabolism and
Esposito et alfunction. Candidate genes included TLR-4, IL-1a, IL-1b, IL-4,
IL-6, IL-8, IL-10, IFN-g, TNF-a1, TNF-a2, lymphotoxin a
(LTA), mannose-binding lectin 2 (MBL2), transforming growth
2 | www.md-journal.comfactor b1 (TGFB1), nitric oxide synthase 2 (NOS2), poly(ADP-
Ribose) polymerase-1 (PARP1), proton-coupled divalent metal
ion transporter member 1 (SLC11A1), calpain 14 (CAPN14),
mucin 2 (MUC2), mucin 5AC/AB (MUC5AC/AB), surfactant
protein D (SFTPD), tumor protein 73 (TP73), serine protease
inhibitors (serpine1), receptor-regulated SMAD2 (SMAD2),
receptor-regulated SMAD4 (SMAD4), sodium channel vol-
tage-gated type I beta subunit (SCN1b), dynein axonemal heavy
chain 5(DNAH5), BPI fold containing family A member 3
(BPIFA3) and 4P (BFIFA4P), Fas cell surface death receptor
(FAS), CD14, F-box protein 11 (FBXO11), and schlafen family
member 5 (SLFN5). These SNPs are involved in causing or
determining the severity or outcome of infectious or chronic
immune-mediated diseases in experimental animals or humans
or were previously supposed or found to be associated with an
increased risk of developing AOM or otitis media with effusion
(OME) or an abnormal immune response.5–8,10–20 The inves-
tigated genes and SNPs are listed in Table 1.
DNA was extracted using the Masterpure DNA Purifi-
cation kit (Epicentre, Madison, FL) in accordance with the
manufacturer’s instructions, and a 50mL final elution volume
was obtained after purification. Single nucleotide polymorph-
isms in the 33 genes were genotyped using the Custom TaqMan
Array Microfluidic Cards genotyping system on an ABI
7900HT (Applied Biosystems, Foster City, CA). After PCR
amplification, the alleles were detected by means of end-point
analysis using SDS and the TaqMan Genotyper software
(Applied Biosystems, Foster City, CA). The data were entered
into a Progeny database (Progeny Software, LLC, South Bend,
IN) to generate datasets for analysis.
Statistical Analysis
The categorical data were compared between the groups
using contingency table analysis with Fisher’s exact test. The
continuous data were analyzed using a 2-sided Wilcoxon rank-
sum test after ensuring that they were not normally distributed
(by means of the Shapiro–Wilk statistic).
Genotype frequencies were determined by direct counting.
To investigate Hardy–Weinberg equilibrium (HWE), the
expected number of each genotype was compared with the
observed number, and potential deviations were assessed using
Fisher’s exact test. Univariate odds ratios (OR), their 95%
confidence intervals (CI), and pertinent P values obtained by
Fisher’s exact test were calculated to measure the associations
between selected SNPs and (1) susceptibility to AOM by
comparing all the children with rAOM and controls and (2)
susceptibility to rAOM without TMP with respect to rAOM and
at least 1 episode with TMP. The data were controlled for
multiple testing using the false discovery rate method (with the
Benjamini–Hochberg procedure). All of the statistical analyses
were made using the R software package, version 3.1.1, with
library genetics and epitools added.
RESULTS
A total of 200 children with rAOM (129 men; median age,
31 months) and 200 healthy controls (129 men; median age, 31
months) were enrolled. Among the children with rAOM, 84
(42.0%) had never experienced TMP, and 116 had a history of
rAOM with TMP. Their demographic and clinical character-
Medicine  Volume 94, Number 42, October 2015istics are reported in Table 2. The 2 groups were similar for all
of the studied variables. None of the healthy controls had a
previous history of rAOM.
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TABLE 1. Gene and Single Nucleotide Polymorphisms (SNPs)
Gene dbSNP HGVS Description
Functional
Consequence Position (bp) Chr
Gene
Location
SLC11A1 rs17221959 NG_012128.1:g.10879C>T Synonymous codon 218387907 2 Exon
SLC11A1 rs17235409 NG_012128.1:g.17981G>A Missense 218395009 2 Exon
SLC11A1 rs2276631 NG_012128.1:g.7262C>T Synonymous codon 218384290 2 Exon
SLC11A1 rs2279014 NG_012128.1:g.19425C>T 30UTR variant 218396453 2 Intergenic
SLC11A1 rs2279015 NG_012128.1:g.17519G>A Intron variant 218394547 2 Intron
SLC11A1 rs2695343 NG_012128.1:g.13672A>G Intron variant 218390700 2 Intron
SLC11A1 rs3731863 NG_012128.1:g.10457C>T Intron variant 218387485 2 Intron
SLC11A1 rs3731865 NG_012128.1:g.8252G>C Intron variant 218385280 2 Intron
SLC11A1 rs7576974 NG_012128.1:g.6039C>T Synonymous codon 218383067 2 Exon
BPIFA3 rs17305657 NC_000020.11:g.33218782T>C Intron variant 33218782 20 Intron
DNAH5 rs17265607 NG_013081.1:g.135237T>G Intron variant 13814244 5 Intron
BPIFA4P rs17396317 NC_000020.11:g.33202571G>A Nc transcript variant 33202571 20 Exon
SERPING1
(C1INH)
rs4926 NG_009625.1:g.21963G>A Missense 57614516 11 Exon
CAPN14 rs13408922 NC_000002.12:g.31221960C>A Intron variant 31221960 2 Intron
CAPN14 rs13386745 NC_000002.12:g.31222749A>G Intron variant 31222749 2 Intron
CAPN14 rs13386850 NC_000002.12:g.31222825A>C Intron variant 31222825 2 Intron
NDUFA2
(CD14)
rs778591 NG_021417.1:g.6887C>T Intron variant 140645899 5 Intron
FAS rs12765241 NG_011541.1:g.15647C>T Intron variant 88980744 10 Intron
FBXO11 rs330787 NG_008397.1:g.96438T>C Intron variant 47814238 2 Intron
IFNg rs12369470 NC_000012.12:g.68151116T>C Downstream variant 68151116 12 Intergenic
IL10 rs1800896 NG_012088.1:g.3943A>G Upstream variant 2KB 206773552 1 Intergenic
IL10 rs3021094 NG_012088.1:g.5888A>C Intron variant 206771607 1 Intron
IL1a rs6746923 NC_000002.12:g.112795849A>G Upstream variant 112795849 2 Intergenic
IL1b rs1143627 NG_008851.1:g.4970C>T Upstream variant 2KB 112836810 2 Intergenic
IL1b rs3917368 NC_000002.12:g.112825205C>T Downstream variant 112825205 2 Intergenic
IL4 rs243250 NC_000022.11:g.33990089C>T Upstream variant 33990089 22 Intergenic
IL6 rs10499563 NC_000007.14:g.22720869T>C Upstream variant 22720869 7 Intergenic
IL8 rs2227306 NG_029889.1:g.5833C>T Intron variant 73741338 4 Intron
MBL2 rs1800450 NG_008196.1:g.5226G>A Missense 52771475 10 Exon
MUC2 rs7934606 NC_000011.10:g.1100037C>T Intron variant 1100037 11 Intron
MUC5AC/
MUC5B
rs6421966 NC_000011.10:g.1133071G>T Upstream variant 1133071 11 Intergenic
NOS2 rs2297518 NG_011470.1:g.35959C>T Missense 27769571 17 Exon
PARP1 rs1136410 NC_000001.11:g.226367601A>G Missense 226367601 1 Exon
SCN1B rs2278996 NG_013359.1:g.14190A>C 30 UTR variant 35039877 19 Intergenic
SERPINE1 rs2227631 NG_013213.1:g.4160A>G Upstream variant 2KB 101126257 7 Intergenic
SFTPD rs1923539 NC_000010.11:g.79935194G>A Downstream variant 79935194 10 Intergenic
SLFN5 rs1564580 NC_000017.11:g.35236775T>C Upstream variant 35236775 17 Intergenic
SMAD2 rs4940086 NG_029946.1:g.16209A>G Intron variant 47919936 18 Intron
SMAD4 rs12958604 NG_013013.2:g.70916A>G Intron variant 51033955 18 Intron
TGFb1 rs10417924 NC_000019.10:g.41327262T>C Downstream variant 41327262 19 Intergenic
TLR4 rs4986790 NG_011475.1:g.13843A>G Missense 117713024 9 Exon
TLR4 rs4986791 NG_011475.1:g.14143C>T Missense 117713324 9 Exon
TLR4 rs2737191 NC_000009.12:g.117700437A>G Upstream variant 117700437 9 Intergenic
LTA rs2229092 NG_012010.1:g.5882A>C Missense 31572980 6 Exon
TNFa.1 rs361525 NG_007462.1:g.4752G>A Upstream variant 2KB 31575324 6 Intergenic
TNFa.1 rs1800629 NG_007462.1:g.4682G>A Upstream variant 2KB 31575254 6 Intergenic
TNFa.2 rs1799724 NG_007462.1:g.4133C>T Upstream variant 2KB 31574705 6 Intergenic
TP73 rs3765766 NG_017035.2:g.70532T>C Intron variant 3718096 1 Intron
Bp¼ base pairs; chr¼ chromosome; HGVS¼Human Genome Variation Society–Genome; SNPs¼ single nucleotide polymorphisms.
Build 37.1 (www.ncbi.nlm.nih.gov); the position reflects the distance from the short-arm telomere.
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TABLE 2. Demographic, Clinical, and Familial Characteristics of Subjects With Recurrent Acute Otitis Media (rAOM) by Disease
Characteristics
Characteristics
Children With
rAOM (n¼ 200)
rAOM Without
TMP (n¼ 84)
rAOM With
TMP (n¼ 116) P Value
Median age (range), months 31 (10–121) 30.5 (11–73) 31 (10–121) 0.649
Males, n (%) 129 (64.5) 54 (64.3) 75 (64.7) 1
Caucasian ethnicity, n. (%) 191 (95.5) 79 (94.0) 112 (96.6) 0.96
Older siblings, n (%) 120 (60) 50 (59.5) 70 (60.3) 1
Day-care attendance, n (%) 159 (79.5) 71 (84.5) 88 (75.9) 0.157
Pacifier use, n (%) 83 (41.2) 36 (42.9) 47 (40.5) 0.772
Exposed to passive
smoking, n (%)
41 (20.5) 16 (19) 25 (21.6) 0.725
History of allergy, n (%) 30 (15) 12 (14.3) 18 (15.5) 0.844
Vaccinated with 13-valent
pneumococcal
vaccine, n (%)
153 (76.5) 62 (73.8) 91 (78.4) 0.5
Vaccinated with
influenza vaccine, n (%)
129 (64.5) 48 (57.1) 81 (69.8) 0.073
Median AOM episodes
since birth (range)
6 (3–21) 6 (3–20) 6 (3–21) 0.624
Median AOM episodes in
the last 6 months (range)
3 (0–8) 2.5 (0–8) 3 (0–8) 0.43
Median AOM episodes in the
last 12 months (range)
5 (3–14) 5 (3–12) 5 (3–14) 0.297
P¼
Esposito et al Medicine  Volume 94, Number 42, October 2015Table 3 lists the genotype frequencies with differences in
the selected SNPs between the children with rAOM and other-
wise healthy controls. As shown, INFg rs 12369470CT was
significantly less common in the children with rAOM than in
healthy controls (OR 0.5, 95% CI 0.25–1, P¼ 0.04). Similarly,
although not significant at the conventional 5% level, IL-1b rs
1143627G and TLR-4 rs2737191AG were less frequently
detected in the children with rAOM than in controls (OR
0.57, 95% CI 0.31–1.05, P¼ 0.06; OR 0.68, 95% CI 0.43–
1.05, P¼ 0.07, respectively). The opposite was observed for IL-
8 rs2227306CT, which was found more frequently among the
children with rAOM than in the healthy controls, although the
difference was not statistically significant in this case (OR 1.52,
95% CI 0.97–2.04, P¼ 0.06). No other relevant genetic vari-
ation association was found between the children with rAOM
and those without.
Table 4 summarizes the genotype frequencies with differ-
ences in the selected SNPs between the children with rAOM
with TMP and those who did not experience TMP. The SNP IL-
10 rs1800896TC and the IL-1a rs6746923A and AG SNPs were
significantly more and less common, respectively, among chil-
dren without a history of TMP than among those who suffered
from this complication (OR 2.17, 95% CI 1.09–4.41, P¼ 0.02,
AOM¼ acute otitis media; rAOM¼ recurrent acute otitis media; TMand OR 0.42, 95% CI 0.21–0.84, P¼ 0.01, respectively). The
other SNPs were similar in both groups of children with rAOM,
regardless of the history of TMP.
DISCUSSION
The results of this study contribute to the knowledge aboutthe relationship between genetics and rAOM. Together with
data regarding the potential role of SNPs in conditioning rAOM,
this study suggests for the first time that genetics might be
4 | www.md-journal.comimplicated in the determination of AOMwith TMP. Concerning
rAOM, this study shows that the SNP rs 12369470CT of the
IFN-g gene is less common among children with rAOM than in
healthy controls, which suggests that this genetic variant might
protect children from repeated AOM episodes. Although they
are not supported by a statistically significant difference at the
conventional 5% level, the same conclusions could be drawn for
the SNP rs 1143627G of the IL-1b gene and the SNP r-
s2737191AG of the TLR4 gene. Conversely, a negative effect
with an increased risk of rAOM seems to be associated with the
IL-8 rs2227306CT SNP, which was more common among
children with rAOM than in healthy controls, although the
difference between the groups did not reach statistical signifi-
cance in this case. For the further study, it is suggested that
increasing the number of patients with rAOMmight increase the
statistical power of a similar study.
The impact of polymorphisms of the IFNg, IL-1b, and
TLR4 genes has been well studied in several clinical conditions,
including AOM, with conflicting results. The protective effect
of the IFNg rs 12369470CT SNP found in this study is new
information that might be useful for differentiating otitis-prone
children from those for whom rAOM is less likely. Gentile et al
found that genetic variations of the IFNg gene were associated
with an increased frequency of AOM.21 Ilia et al reported that
the same SNP could be considered a predictor of progress to
AOM following upper respiratory infection (URI).22 By con-
trast, results consistent with our study were published by Alper
et al, who did not find any association between this SNP and the
development of AOM in children with URIs.23
The data describing the IL-1b rs 1143627G and TLR4
tympanic membrane perforation.rs2737191AG SNPs merit further evaluation because the pro-
tective effect associated with these genetic variations is not
substantiated by the statistical analysis and was not found in
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 3. Genotype Frequencies With Differences in the Selected SNPs Between Controls and Children With Recurrent Acute
Otitis Media (rAOM)
Gene and
Polymorphic
Alleles
Control
Group
(n¼ 200)
Children
With rAOM
(n¼ 200)
HWE, x2
Controls
HWE, x2
rAOM Outcome
N % N % P Value P Value OR 95% CI P Value

IFNg.rs12369470
C 3 1.5 0 0 0.18 1 0 0–2.24 0.11
C/T 29 14.5 16 8 0.5 0.25–0.99 0.04
T 168 84 184 92 1 (reference)
IL1b.rs1143627
C 77 38.5 94 47 0.06 0.11 1 (reference)
C/T 83 41.5 79 39.5 0.78 0.5–1.23 0.27
T 39 19.5 27 13.5 0.57 0.31–1.05 0.06
NA 1 0.5 0 0
IL8.rs2227306
C 90 45 75 37.5 0.01 0.88 1 (reference)
C/T 74 37 94 47 1.52 0.97–2.4 0.06
T 36 18 31 15.5 1.03 0.56–1.9 1
TLR4.rs2737191
A 88 44 104 52 0.87 0.71 1 (reference)
A/G 89 44.5 71 35.5 0.68 0.43–1.05 0.07
G 20 10 14 7 0.59 0.26–1.32 0.19
NA 3 1.5 11 5.5
¼
. No
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SNPs were examined. Nokso-Koivisto et al studied the occur-
rence of AOM following URI and concluded that the presence
of the IL-1b rs1143627G SNP did not increase susceptibility to
AOM.24 By contrast, the IL-1b rs1143634 SNP was associated
with a higher risk of severe inflammation after AOM.25 Sim-
ilarly, conflicting data were reported for the TLR4 SNPs. The
CI¼ confidence intervals; HWE¼Hardy–Weinberg equilibrium; NA
P values from univariate analysis, not adjusted for multiple testingTLR4 rs4986790 and TLR4 rs49867912 SNPs, 2 of the SNPs
evaluated in this study for which no association with rAOMwas
found, were reported to be more common in otitis-prone
TABLE 4. Genotype Frequencies With Differences in the Selecte
(rAOM) With Tympanic Membrane Perforation (TMP) or rAOM W
Gene and
Polymorphic
Alleles
Children With
rAOM and TMP
(n¼ 116)
Children With
rAOM Only
(n¼ 84)
N % N %
IL10.rs1800896
C 19 16.4 12 14
T/C 51 44 52 61
T 46 39.7 20 23
IL1a.rs6746923
A 24 20.7 13 15
A/G 63 54.3 35 41
G 29 25 36 42
CI¼ confidence intervals; HWE¼Hardy–Weinberg equilibrium; NA¼
P values from univariate analysis, not adjusted for multiple testing. No
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.children by Emonts et al13 but were considered independent
from AOM by Carroll et al.26
The IL-8 rs2227306CT SNP seems to be associated with
an increased risk of rAOM because it is more common among
children with this condition than controls. Although the differ-
ence between groups did not reach statistical significance, this
finding merits attention and further studies to confirm the data
not available; OR¼ odds ratio.
ne of the P values was significant after adjusting for multiple testing.because IL-8 has been repeatedly reported as a factor that
increases susceptibility to ear disease and chronic ear inflam-
mation both in vitro and in vivo.27,28
d SNPs Between Children With Recurrent Acute Otitis Media
ithout TMP
HWE, x2
Controls
HWE, x2
rAOM Outcome
P Value P Value OR 95% IC P Value

.3 0.44 0.03 1.45 0.53–3.86 0.49
.9 2.33 1.17–4.77 0.01
.8 1 (reference)
.5 0.46 0.35 0.44 0.17–1.08 0.06
.7 0.45 0.22–0.89 0.02
.9 1 (reference)
not available; OR¼ odds ratio.
ne of the P values was significant after adjusting for multiple testing.
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The IL-10 rs1800896TC SNP and the IL-1a rs6746923A
and AG SNPs were associated with a reduced or an increased
risk, respectively, of rAOM with TMP. Differences in genetic
characteristics between subjects with and without TMP are not
surprising because AOM complicated by TMP significantly
differs from AOMwithout this complication in several factors.
AOM with TMP is frequently caused by Streptococcus pyo-
genes, a bacterial pathogen that is not common inAOMwithout
TMP, and it frequently has a complicated course.29 Moreover,
the administration of vitamin D 30 or influenza vaccine,31
which can reduce the incidence of new episodes of AOM in
children who have never had TMP, is not effective in patients
with rAOM that is occasionally complicated by TMP. The
importance of SNPs in IL-10 and IL-1a in conditioning
susceptibility to respiratory infections has been reported by
others. Nokso-Koivisto et al showed that the IL-10
rs1800896TC SNP was more common in subjects with a
reduced risk of URI and an occurrence of AOM during URI
episodes,24 whereas Joki-Erkkila et al found that SNPs in the
IL-1a gene were associated with an increased risk of rAOM.32
Conversely, the role of IL-1a in predisposing to ear diseases is
supported by the demonstration that the expression of IL-1a is
higher in cases of chronic otitis media, with a strong positive
correlation between the cytokine level and the degree of bone
destruction.33 However, the findings of this study extend
previous knowledge and seem to indicate that genetic variants
of the IL-1a genes might be associated with complicated AOM
at risk of negative evolution.
In this study, several associations between variants in genes
encoding for factors of innate or adaptive immunity and the
occurrence of rAOMwere identified, which confirmed the role of
genetics in conditioning susceptibility toAOM.Moreover, for the
first time, an association between genetic variants of IL-10 and
IL-1a and the risk of development of rAOMcomplicated byTMP
was indicated. However, before these data can be used in clinical
practice, linkage studies and genome-wide association studies
might be useful to definitively solve the problemof the real role of
genetic variants in conditioning susceptibility to rAOMand in the
development of complicated cases.
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